Search - tctmd.com

Displaying 121 - 140 of 194

Sort: Relevancy | Date

Presentation TCT 2024

The Intrepid TTVR Clinical Program

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

PASCAL Case Presentation #3 and Discussion

Presenter: Sammy Elmariah

October 28, 2024

Presentation TCT 2024

PASCAL Case Presentation #2 and Discussion

Presenter: Molly Szerlip

October 28, 2024

Presentation TCT 2024

EVOQUE system overview & case review

Presenter: Pedro Villablanca

October 28, 2024

Presentation TCT 2024

PASCAL Case Presentation #1 and Discussion

Presenter: Jorge Castellanos

October 28, 2024

Presentation TCT 2024

PASCAL Precision system latest clinical data & predictability study

Presenter: Sam Dawkins

October 28, 2024

Presentation TCT 2024

TCT 748: Early Economic Analysis of Integrated Robotic Assisted Augmented Reality (AR) Visualization for Transcatheter Tricuspid Valve Repair (TTVR) or Percutaneous Tricuspid Trans-Catheter 'Edge-to-Edge' Repair (T-TEER)

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 1461: Navigating Unchartered Waters: Successful Management of RV Pseudoaneurysm Post VIV TTVR in a High-Risk Tricuspid Valve Patient

Presenter: Huseyin Arman

October 28, 2024

Presentation TCT 2024

Predicting Outcomes in Patients Undergoing TTVr for Severe TR: Role of Right Ventricular Free Wall Longitudinal Strain-Derived Pulmonary-Arterial Coupling

Presenter: Jennifer von Stein

October 28, 2024

Presentation TCT 2024

TCT 1247: A Novel TTVR System in a Patient Presenting With Challenging Right Heart Anatomy

Presenter: Anita Asgar

October 27, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Presenter: Azeem Latib

June 07, 2024

Presentation NY Valves 2024

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Presenter: Rishi Puri

June 07, 2024

Presentation NY Valves 2024

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Presenter: Elaine Wan

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Presenter: Brian P. O'Neill

June 06, 2024

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

TricValve: Technology and Clinical Update

Presenter: Rishi Puri

June 06, 2024

Advertisement

The Intrepid TTVR Clinical Program

The Cardiovalve TTVR Clinical Program

PASCAL Case Presentation #3 and Discussion

PASCAL Case Presentation #2 and Discussion

EVOQUE system overview & case review

PASCAL Case Presentation #1 and Discussion

PASCAL Precision system latest clinical data & predictability study

TCT 748: Early Economic Analysis of Integrated Robotic Assisted Augmented Reality (AR) Visualization for Transcatheter Tricuspid Valve Repair (TTVR) or Percutaneous Tricuspid Trans-Catheter 'Edge-to-Edge' Repair (T-TEER)

TCT 1461: Navigating Unchartered Waters: Successful Management of RV Pseudoaneurysm Post VIV TTVR in a High-Risk Tricuspid Valve Patient

Predicting Outcomes in Patients Undergoing TTVr for Severe TR: Role of Right Ventricular Free Wall Longitudinal Strain-Derived Pulmonary-Arterial Coupling

TCT 1247: A Novel TTVR System in a Patient Presenting With Challenging Right Heart Anatomy

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

TricValve: Technology and Clinical Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content